Travel Medicine Advisor Archives – October 1, 2004
October 1, 2004
View Archives Issues
-
Typhoid Fever: Which Travelers Have High Risk?
The great majority of typhoid fever cases diagnosed in the United States occur in patients who have visited friends and relatives overseas, especially travelers returning from South-central and Southeast Asia, including short-term travelers. Among other precautions, typhoid fever vaccine should be recommended to these high-risk travelers. -
Last Minute Travelers and Hepatitis Prevention!
Travelers presenting 3 to 4 weeks in advance for travel to areas with high prevalences for hepatitis A and B can benefit from an accelerated dosing schedule using either monovalent or combined hepatitis A and B vaccines. Those who present 2 weeks in advance can be fully protected against hepatitis A; they should be encouraged to begin the vaccine series for hepatitis B even though optimal levels of hepatitis B immunity cannot be provided. -
Fatal Myositis Due to a Mosquito Pathogen
A Microsporidia species, never previously isolated from deep tissues of humans, was the cause of fatal myositis in a patient with diabetes and rheumatoid arthritis, who was being treated with infliximab. -
Diet in the Treatment of Travelers’ Diarrhea
A randomized, controlled trial involving North American students visiting Mexico suggests that a restricted diet does not shorten the duration or severity of symptoms during travelers diarrhea.